Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trialAna Oaknin, Juan Cueva, Laurence Gladieff et al.|The Lancet|2023Cited by 225
774P Initial management and long-term outcome of ovarian clear cell carcinoma (OCCC) in the French multicentre ESME databaseM. Zenatri, Paule Augereau, Laurence Gladieff et al.|Annals of Oncology|2024Cited by 0